Bumrungrad Hospital Public Company Limited
BUGDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $199,953 | $6,024,062 | $6,140,958 | $6,473,164 |
| % Growth | -96.7% | -1.9% | -5.1% | – |
| Cost of Goods Sold | $3,060,588 | $2,863,692 | $3,039,865 | $3,259,233 |
| Gross Profit | $3,452,025 | $3,160,370 | $3,101,093 | $3,213,931 |
| % Margin | 1,726.4% | 52.5% | 50.5% | 49.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $889,673 | $821,314 | $920,041 | $952,938 |
| SG&A Expenses | $1,056,226 | $961,456 | $1,083,815 | $1,141,954 |
| Sales & Mktg Exp. | $166,553 | $140,142 | $163,774 | $189,016 |
| Other Operating Expenses | -$65,876 | -$79,613 | -$65,295 | -$53,166 |
| Operating Expenses | $990,350 | $881,843 | $1,018,520 | $1,088,788 |
| Operating Income | $73,155 | $2,278,527 | $2,082,573 | $2,125,143 |
| % Margin | 36.6% | 37.8% | 33.9% | 32.8% |
| Other Income/Exp. Net | $4,178 | $49,919 | $61,354 | $63,414 |
| Pre-Tax Income | $77,333 | $2,328,446 | $2,143,927 | $2,188,557 |
| Tax Expense | $14,294 | $448,882 | $400,095 | $278,957 |
| Net Income | $62,677 | $1,857,633 | $1,733,830 | $1,902,961 |
| % Margin | 31.3% | 30.8% | 28.2% | 29.4% |
| EPS | 0.079 | 2.34 | 2.18 | 2.39 |
| % Growth | -96.6% | 7.3% | -8.8% | – |
| EPS Diluted | 0.072 | 2.14 | 2 | 2.19 |
| Weighted Avg Shares Out | 794,964 | 794,933 | 794,933 | 794,915 |
| Weighted Avg Shares Out Dil | 867,415 | 867,415 | 867,415 | 867,415 |
| Supplemental Information | – | – | – | – |
| Interest Income | $50,215 | $52,487 | $63,391 | $65,610 |
| Interest Expense | $888 | $2,224 | $2,026 | $2,050 |
| Depreciation & Amortization | $8,296 | $258,880 | $255,714 | $274,840 |
| EBITDA | $85,662 | $2,589,550 | $2,401,667 | $2,465,447 |
| % Margin | 42.8% | 43% | 39.1% | 38.1% |